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COMMISSION STAFF WORKING DOCUMENT 
Principles for an EU contribution to the Global Fund to Fight HIV/AIDS, Tuberculosis 
and Malaria (GFATM) with a view to the 2006/2007 Replenishment Process 
EXECUTIVE SUMMARY 
1. The EU, including the EC, has been a founding member of the GFATM since its 
inception in 2001/2002. In financial terms, the EU has so far provided more than 
US$ 1.6 billion to the GFATM. This includes the substantial EC contribution over 
the last three years which amounts to € 374.5 million (out of a pledge of € 460 
million for the period 2001-2006). The EC, represented by the Commission, has been 
an active member of the GFATM Board and has been involved in two of the 
GFATM committees. 
2. In 2004, the Board of the GFATM agreed on the need to establish a new funding 
system to guarantee long-term and sustainable financial resources for the Fund. The 
current system based on voluntary and ad hoc contributions does not allow long-term 
and effective planning of the Fund’s operations. The EC fully endorsed the decision 
to launch the replenishment process, which represents a great opportunity for the 
European Union to continue to demonstrate leadership in the fight against 
HIV/AIDS, tuberculosis and malaria. 
3. The Commission has responded to the call from the Council (see the Council 
Conclusions adopted by the GAERC on 23 November 2004) to facilitate the 
preparations for the replenishment process at European level and has taken the 
initiative of preparing a Staff Working Paper. This paper is only intended to provide 
EU Member States with relevant information regarding the replenishment process 
and can not be used as a financial commitment, nor can it result in any financial 
commitment which prejudges the annual budget procedure, nor the conclusion of 
negotiations on the future financial framework (2007 – 2013). It presents a few 
options for a possible EU role with a view to the 2005 Replenishment Conferences. 
These are based on the resource needs estimates made by the GFATM Secretariat 
and other institutions engaged in the fight against the three diseases. These options or 
scenarios are presented to facilitate a necessary debate, but do not constitute 
indications of the Commission’s funding intentions at this stage. The objective 
pursued through this Working Document is thus to play a coordinating political role 
for the EU in the Global Fund. 
4. The replenishment mechanism is needed in order to increase the predictability of 
GFATM resources over a certain period of time (2006 and 2007). The EC fully 
supports the proposal to undertake a replenishment process for an initial period of 
two years, namely 2006 and 2007. It is quite a long and complex process which will 
require extensive discussions and consultations among all stakeholders. Before the 
end of year two of the replenishment period, GFATM donors will review the process, 
assess its results and make decisions as to its continuation in the future. The 
replenishment process will improve the effectiveness of GFATM operations. It will 
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result in more efficient liquidity management and enable the GFATM to possibly 
back its commitments with instruments other than cash, such as promissory notes. 
5. Two major donor meetings are planned in the course of 2005 to discuss the 
replenishment process. The first will be hosted by the Swedish Government in 
Stockholm on 14/16 March 2005 while the second will be hosted by the British 
Government in early September. 
6. The GFATM, established as a financing mechanism, has proved over the years to be 
able to channel increasing financial resources. As of December 2004, the Fund had 
approved – through four rounds of proposals – a total of 312 programmes in 128 
countries for a total of amount of over US$ 3 billion. A fifth round of proposals was 
launched at the end of last year and will come up for approval, provided that the 
necessary resources are made available, in September 2005. This document however 
does not intend to provide an evaluation of the Global Fund as a great number of 
reports are currently being discussed in a separate contexts. 
7. The major international organizations dealing with the three diseases, namely 
UNAIDS and WHO (Roll Back Malaria and Stop TB) are actively working in 
collaboration with some bilateral donors to come up with clear financial scenarios 
regarding future global targets and financial needs. Some preliminary figures are 
provided in this paper. The GFATM Secretariat has worked out some financial 
estimates for future years based on its current business model, which are provided in 
the paper. Based on such estimates, to run its operations the Fund would need 
US$ 2.3 billion in 2005, US$ 3.6 billion in 2006 and approximately US$ 3.7 
billion in 2007 (including US$ 0.1 billion for operating expensens in 2006 and 
2007). 
8. Based on the GFATM figures on donor pledges for 2005, 2006 and 2007, there is 
clearly a striking resource gap which the donor community will have to take into 
consideration. According to the best estimates for 2005, the GFATM still needs 
approximately US$ 0.9 billion to cover both the costs of phase II renewals of grants 
previously approved and the cost of Round 5 of proposals. An ad hoc appeal will be 
launched shortly by the Chair of the GFATM Board and the GFATM Executive 
Director. The Replenishment Meeting in Stockholm (14/16 March 2005) will provide 
a unique opportunity to current and potential GFATM donors to announce and/or 
confirm pledges for 2005. As to 2006 and 2007, the financial gap currently 
amounts to approximately US$ 2.9 billion for 2006 and US$ 3.3 for 2007. 
9. The EU (EC and EU Member States) contribution to the GFATM in absolute terms 
has changed over the years (US$ 0.46 billion in 2001/2002, US$ 0.42 billion in 2003 
and US$ 0.73 billion in 2004). In percentage terms, the EU’s share of the overall 
contributions received by the GFATM has been between 48% and 55%. 
10. With a view to the Replenishment Conference in the United Kingdom scheduled in 
early September 2005, the EC intends to launch a debate in the EU on how to share 
among GFATM donors, and more particularly among EU partners, the financial 
resources needed by the Fund in the replenishment period, i.e. 2006 and 2007. A few 
possible options are presented in this paper to the European Member States for 
discussion: 
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• Option1 
Continuing the current trend, the EU commits itself to continue providing 50% or 
more of the annual contributions to the GFATM. Such a contribution would 
complement the EC/EU’s commitments including in research and ensure 
considerable political visibility for the Union confirming its leadership in the fight 
against HIV/AIDS and the other two diseases. 
• Option2 
Based on the commitment expressed by some world leaders at the G8 Summit in 
June 2003 (and reiterated at the GFATM Donors Conference in July that year), 
the EU agrees to split the annual contributions to the GFATM equally with the 
USA (the main individual donor to the GFATM) and the other non-EU donors 
(Canada, Japan, Australia, private foundations, etc.): this is the so-called “33% 
option”. 
11. The EU will also have to engage in a debate on how to share among the Member 
States and the EC, the annual contributions to the GFATM in 2006 and 2007. This 
paper provides three options for discussion: 
• Current EU donors (including the EC) proportionally increase their annual 
contributions to the GFATM based on the level of resources provided in the last 
two years (2003 and 2004). 
• New EU donors join the GFATM (at present only 17 EU Member States have 
provided a financial contribution to the GFATM), which would enable the key for 
each EU donor’s contribution to be reviewed as the financial burden would be 
shared among a larger number of European partners. 
• All EU Member States agree to contribute to the GFATM and to apply the GNI 
key to calculate the contribution of each individual donor. Should this option be 
applied, the EC annual contribution could be calculated according to a different 
key. 
12. This paper will be presented to the Council in early March 2005, aiming at launching 
an initial debate among EU Member States on some of the relevant issues pertaining 
to this process with a view to the Replenishment Meeting in Stockholm in mid-
March. 
1. INTRODUCTION 
1.1. Scope and context of the paper 
The main scope of this paper is to develop an EU position on the replenishment process for 
the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria (GFATM). Based on future 
resource needs estimates presented by the GFATM Secretariat and several international 
institutions, the EU (EC and EU Member States) needs to engage in a thorough debate as to 
how GFATM donors, and more particularly EU partners, could share the financial burden. 
The paper is also intended to provide a clear picture of the resource gap the GFATM is 
currently facing for 2005 and the following two years. 
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The EU (EC and Member States) has been increasingly engaged in the last 5 years in 
combating poverty-related diseases through a vast array of instruments and channels of 
financing. In particular, the EC provides technical and financial support to combat HIV/AIDS, 
tuberculosis, malaria and other diseases affecting developing countries through bilateral 
programmes financed by the EC budget and through the EDF (EC budget assistance was 
provided through geographical lines amounting to approximately € 245 million a year 
excluding general budget support). EC action has been remarkable, however, for a number of 
global multi-donor initiatives, such as the GFATM, promoted and supported by the donor 
community, including UN agencies, the private sector, civil society and some developing 
countries. 
In 2004 the Commission adopted and presented to the Council and the European Parliament 
”A coherent European policy framework for external action to confront HIV/AIDS, 
tuberculosis and malaria” (COM (2004) 726). EU Member States have welcomed this policy 
framework, which is aimed at ensuring the necessary policy coherence and synergy among 
different policy areas such as trade, health, research, information technologies, development 
and external relations. 
The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, established in January 2002, 
represents a visible and effective global initiative which has been able to provide an adequate 
and effective response to the increasing demand for financial resources to confront the three 
diseases. In order to ensure more predictable funding and, in turn, a more effective response 
to partner countries’ needs, the Board of the GFATM has agreed to launch a replenishment 
process to cover the financial needs of the GFATM in the years 2006 and 2007. GFATM 
donors, including the EC, will be requested to give a coherent and cohesive response to such 
an important challenge. The replenishment process represents a unique opportunity for the EU 
to prove its leadership in this challenging endeavour in which it has so far played a key role. 
The EU (EC and Member States) is currently the GFATM’s major donor and over the years 
has provided between 48% and 55% of its total resources. 
The call for additional contributions to the GFATM should not be perceived as an isolated 
event. It needs, on the contrary, to be seen in the wider context of the efforts that the 
international community will need to make under the review of the Millennium Development 
Goals (MDGs) planned for September 2005. The ongoing review of the progress made in the 
last five years in the achievement of the MDGs proves that scant results have been achieved 
in terms of halting the spread of HIV/AIDS or the incidence of malaria and other major 
transmissible diseases. 
The need to make further and more substantive progress in the achievement of the MDGs 
calls for additional resources from the donor community. EU Member States committed 
themselves in 2002 (at the International Conference for Development Financing, Monterrey) 
to progressively increasing their ODA. As indicated in the 2004 EU Annual Monitoring 
Report on the Monterrey commitments, good progress has been made in the last two years 
(the EU as a whole is well on course to achieve the 2006 targets). Nevertheless, available 
resources are not sufficient to cover the increasing needs of partner countries, hence the need 
for additional efforts by the international community. The EU, reflecting its position as the 
largest donor worldwide and its leading role in Monterrey, recently agreed to consider the 
possibility of providing increased resources for development. 
The public funding already identified will not be sufficient to cover existing and emerging 
financial needs. The EU has agreed to explore innovative means of financing. To this end a 
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debate on specific initiatives, such as the international taxation proposals set out by France in 
the Landau Report and the IFF promoted by the United Kingdom, was launched towards the 
end of 2004 to complement efforts on increased ODA, and will be further developed in the 
coming months. The role of the International Finance Institutions (IFIs) is also being 
discussed in the light of the need for additional resources for development and poverty 
reduction. 
The debate on the role of the private sector in financing development is also highly relevant to 
the GFATM. The private sector’s role in financing the GFATM has been quite limited so far 
and needs to be further promoted in the light of the need for additional resources. 
2. THE REPLENISHMENT PROCESS 
2.1. Rationale behind the replenishment mechanism and its implications 
The current funding system for the GFATM, based on voluntary and ad hoc donor 
contributions, makes planning for long-term and sustainable programme support quite a 
difficult task. 
The primary objective of the replenishment process is therefore to increase the predictability 
of GFATM resource mobilization in order to reduce to a minimum the risk of slowing down 
or even stopping the Fund’s disbursement capacity even when there is demand for its 
interventions. Several current and potential donors have highlighted the need for a more 
suitable funding system which could render the GFATM’s operations more effective. 
The fact that thousands of people receive anti-retroviral treatment and/or other supplies (such 
as condoms, malaria bed nets, DOTS therapies etc.) financed by the GFATM makes the issue 
of sustainable and predictable funding very important. As a guiding principle, developing 
countries should gradually move towards self-sustaining financial systems. However, faced 
with severe resource constraints, especially in the poorest countries, the global community 
will need to continue to provide support for many years to come. 
The replenishment process is intended to be a voluntary process aimed at creating a strong 
linkage between political support for the GFATM and actual implementation of 
commitments. The replenishment process should aim to cover most of the predictable 
financial needs of the GFATM over a certain period of time to be agreed in advance based on 
a number of considerations. 
The replenishment mechanism can be divided into two pillars, one for public sector 
contributors who would be requested to fill the core funding gap, and one for private sector 
contributors who would be requested to provide ad hoc contributions. This process should be 
linked to a specific communication strategy on GFATM achievements over the years. 
The introduction of the replenishment mechanism will also facilitate the launching of an 
additional round of financing proposals (Round 5) based on the GFATM Board decision of 
November 2004. The GFATM Board agreed that the new call for proposals and related 
guidelines would be issued in March 2005 provided that the required financial resources were 
available. This implies that GFATM donors will be requested to confirm by March 2005 their 
pledges for that year in order to enable the smooth implementation of Round 5. 
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The replenishment process could help to cover a very high proportion (90-100%) of planned 
operational needs for the three diseases. This would make any remaining financial gap 
(arising from an unexpected increase in demand) more easily manageable through ad hoc 
fundraising. 
The replenishment process is closely linked to liquidity management. The introduction of a 
replenishment mechanism would thus not only result in more efficient liquidity management 
but also enable the GFATM to back its commitments with instruments other than cash, 
thereby reducing idle cash balances. As a matter of fact, in March 2004 the Board of the 
GFATM approved a decision according to which donors participating in the replenishment 
mechanism will be asked to back their pledges to the Fund with either cash or promissory 
notes callable on a schedule matching expected Fund disbursements. 
Under GFATM internal procedures, signing a grant agreement requires 100% availability of 
cash or promissory notes on the Trustee account (at the World Bank). This means that if, for 
some reason, actual disbursements by donors do not equal the total pledges given, the grant 
agreement cannot be signed on schedule. In other words, even a temporary shortfall in 
liquidity can have a negative impact on the beneficiaries of the GFATM. The introduction of 
promissory notes would result in the reduction of cash balances held by the GFATM as 
reserves between donor commitments and actual disbursements. Moreover, it would enable 
the GFATM to take into account donor pledges for future years when planning and approving 
new rounds of proposals. 
2.2. Replenishment meetings in 2005 
In October 2003, the Board of the GFATM decided to reform the current funding system and 
to introduce a new model based on periodic replenishments of the Fund. However, the 
replenishment process was officially launched only last autumn with the nomination of the 
United Nations Secretary General, Kofi Annan, as Chair of the Replenishment Conference 
(Mr Sven Sandström from Sweden will act as Vice-Chair). Two meetings have been planned 
in 2005. The first, hosted by the Sweden Swedish Government, will take place in Stockholm 
on 14-16 March; the second, hosted by the United Kingdom, will take place in early 
September. The Stockholm meeting, mainly organised by the GFATM Secretariat, is intended 
to be a forum for discussion among donors on a number of relevant issues such as (i) the 
funding requirements for fighting the three diseases, including projections from key agencies 
and partners on global funding needs and the share of resources which could be channelled 
through the GFATM; (ii) the operational and financial performance of the GFATM based on 
the Secretariat progress report and an independent assessment of the GFATM. Background 
documents will be sent in advance to all stakeholders attending the Meeting. As a result of the 
Stockholm Meeting, donors are expected to confirm their pledges for 2005 (see Table 1) 
which will enable the GFATM Board to smoothly implement Round 5 of the financing 
proposals. 
The second meeting, scheduled in the United Kingdom in early September, is meant to gather 
high-level representatives of the GFATM’s current and potential donors (from both the public 
and private sectors) to announce their 2006 and 2007 contributions. 
The EC has agreed to actively participate in the replenishment process in its capacity as a 
major donor to the GFATM (the EC, represented by the Commission, is currently a Board 
member and the second biggest individual donor in terms of contributions between 2001 and 
2004). All GFATM donors are expected to be closely associated with this process. 
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Key elements of the replenishment process are its duration and the kind of financial needs it 
covers. As regards its duration, it should be considered that long replenishment periods (say 
above four years) would increase donors’ uncertainty and involve substantive costs in terms 
of mid-term reviews needed. On the other hand, very short periods (less than two years) 
would produce disproportionate transaction costs and risks without adding great value to the 
process used at present. A two- to three-year replenishment period seems therefore to be the 
most appropriate. Since the whole process is likely to be completed in September 2005 (at the 
High-Level Replenishment Conference in the United Kingdom), the first replenishment cycle 
should cover 2006 and 2007. A review and assessment of the process towards the end of 2007 
will provide indications as to the need and advisability of further pursuing this principle, 
possibly with slight adjustments, or changing it. 
3. PERFORMANCE AND ADDED VALUE OF THE GLOBAL FUND TO FIGHT HIV/AIDS, 
TUBERCULOSIS AND MALARIA 
3.1. Overall performance 
The Global Fund has enabled so far: 
- 130.000 people to gain access to lifelong antiretroviral treatment 
- 1 million people to be reached with HIV testing and counselling 
- 385.000 people to be treated for tuberculosis under DOTS (the WHO-
recommended TB control strategy) 
- 300.000 people to be treated for malaria 
- 1.350.000 insecticide-treated bednets to be distributed to prevent malaria 
transmission  
The GFATM finances programmes through rounds of financing proposals. To date, four 
rounds have been approved and a fifth has been launched and will come for approval, 
provided that the resources needed are available, at the Board Meeting in September 2005. 
As of December 2004, the GFATM had approved through its four rounds of proposals a total 
of 310 programmes in 127 countries worth a total of approximately US$ 3.1 billion. This 
represents a significant expansion in the global coverage of prevention, treatment and care of 
HIV/AIDS, tuberculosis and malaria. With few exceptions, GFATM funding covers all 
countries that are experiencing the most severe burden of disease or that are at risk. Nearly 
two thirds of the recipient countries are low-income countries (LICs) based on the World 
Bank classification, while one third are lower-middle income countries (LMICs) with severe 
disease burdens or very high infection growth rates. Three per cent of the grants goes to some 
upper-middle-income countries (UMICs) with very high disease burdens or infection growth 
rates. 
In terms of the geographical distribution of the grants approved, 60% of the funding goes to 
Sub-Saharan Africa, 23% is spent in Asia, the Middle East and North Africa, and the 
remaining 17% is shared between Latin America, the Caribbean and Eastern Europe. In terms 
of diseases, just over 56% of grant funding relates to HIV/AIDS, 31% to malaria and 13% to 
tuberculosis. 
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Overall, disbursements are roughly on track. On this point, it should be borne in mind that 
while many other institutions disburse funding on a yearly basis or in one solution only, in the 
case of the GFATM disbursements are based on results measured against quarterly and annual 
targets indicated in the grant agreement. Delays in the early stage of implementation lead 
therefore to a temporary halt in disbursements. Disbursement rates of approved programmes 
are used as an indicator of programme performance. 
 
The GFATM receives proposals through the country coordination mechanisms (CCMs). 
CCMs include broad representation from government authorities, NGOs and other civil 
society institutions, including the communities living with the diseases, multilateral and 
bilateral agencies and the private sector. 
3.2. GFATM Secretariat 
The GFATM Secretariat in Geneva was established as a rather small body with a staff of 150 
people to keep administrative costs to a minimum (The GFATM Secretariat’s main tasks in 
grant management are to prepare the calls for proposals (‘rounds’); to negotiate grant 
agreements for proposals approved by the Board; to disburse funds to recipients based on 
reported results; and to assist in identifying and addressing problems with under-performing 
grants by facilitating contact between recipients and technical agencies. The performance of 
the GFATM Secretariat in grant management can be measured by the time lapse between the 
initial submission of a proposal and the first disbursement of funds. 
Table I: Approvals, commitments and disbursements by funding round 
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3.3. Added value of GFATM 
This document does not intend to provide an evaluation of the Global Fund as a great number 
of relevant reports are currently being discussed in a separate contexts 
(www.theglobalfund.org/en/about/replenishment/).  
The GFATM was mainly established to generate additional public and private resources to 
confront the three diseases. It represents an institution quite different from traditional forms of 
multilateral governance since non-state actors can share decision-making powers and 
financial responsibilities with national governments and institutional donors. Despite that, the 
GFATM is quite reliant on the infrastructure and support of UN agencies, funds and 
programmes. For example, WHO and UNAIDS are expected to provide technical assistance 
at country level and build capacity complementary to national, GFATM-funded programmes. 
The GFATM is using an innovative performance-based model to fund programmes proposed 
by the recipient countries. While the GFATM is not a purchasing institution, funding provided 
to support demand-driven proposals presented by recipient countries can help to reduce prices 
of pharmaceutical products and commodities. The demand generated as a result of GFATM 
operations can also have a medium-term leverage effect on research into new tools to confront 
the three diseases. 
The development of new strategies and action plans as well as the use of specific instruments 
and additional resources, particularly in the case of the GFATM, will imply further policy 
coherence and coordination between EU Member States and the EC. This is particularly true 
in the fight against HIV/AIDs, TB and malaria where both the EC and EU Member States are 
actively involved. 
Developing countries have in some fora expressed positive views on GFATM performance 
and underlined the following positive elements: the principle of ownership (proposals are 
developed at country level); their representation in the GFATM Board; the flexibility offered 
by GFATM funding policy, especially with regard to recurrent costs, which are rarely 
permitted by most other aid agencies (with the exception of the EC); the transparency of 
operations (GFATM activities are accessible on its website, including the results of 
negotiations on pharmaceutical product pricing). 
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4. GFATM AS PART OF THE GLOBAL FINANCING ARCHITECTURE FOR HIV/AIDS, 
TUBERCULOSIS AND MALARIA 
UNAIDS and WHO (Roll Back Malaria and Stop TB), as the main UN agencies concerned by 
the three diseases, are actively involved in the calculation of global targets and financial needs 
to fight the three diseases in the next few years (2006 onwards). 
In order to achieve agreed targets, i.e. to halt and begin to reverse the incidence of malaria by 
2015 and to halve malaria morbidity and mortality by 2010 (Abuja Declaration on malaria), 
the Roll Back Malaria Partnership estimated that 60% of people suffering from malaria should 
have access to treatment, 60% of those at risk should have access to prevention measures (bed 
nets), and 60% of pregnant women should have access to intermittent preventive treatment. 
The annual resource needs by 2006 onwards have been calculated at approximately US$ 2.9 
billion. Total domestic expenditure on malaria in 2004 amounted to US$ 0.3 billion and it has 
been estimated that this value will remain constant. The share of resources to be provided 
annually by the donor community would therefore amount to US$ 2.6 billion. 
The Stop TB partnership has defined a set of targets aimed at reducing the tuberculosis 
burden. The targets include detecting 70% of new active tuberculosis cases, treating cases 
detected through DOTS, curing at least 85% of all treated cases by 2005, and reducing the 
global burden of the disease by 50% by 2010 (compared to 2000 levels). The annual resource 
needs by 2007 onwards has been calculated at US$ 2 billion. Domestic resources should cover 
US$ 1.2 billion annually, and therefore the annual share to be provided by the donor 
community would be US$ 0.8 billion. 
Based on cost estimates made by UNAIDS, the annual resource needs to fight HIV/AIDS 
from 2006 onwards would be approximately US$ 14.5 billion. Since domestic resources are 
expected to cover approximately US$ 3 billion, the portion to be covered annually by the 
donor community would be approximately US$ 11.5 billion. 
Based on the estimated resource needs for the three diseases, the above UN agencies have 
been trying to calculate the share of external resources that should be channelled through the 
GFATM from 2006 onwards. The basic assumption is that the GFATM currently covers (in 
terms of disbursements) approximately 45% of the total needs to fight malaria, 66% of the 
total needs to fight TB and between 20% of the total needs to fight HIV/AIDS. Thus, the 
GFATM should receive US$ 3.6 billion in 2006 to and US$ 4 billion in 2007 to confront the 
three diseases. 
5. PREDICTABLE AND LONG-TERM FINANCING FOR THE GFATM 
5.1. GFATM funding needs in 2005 
Based on the financial figures provided by the GFATM Secretariat (see Table II), the total 
amount currently available for 2005 as contributions pledged is approximately US$ 1.4 
billion. On the expenditures side, GFATM Secretariat forecasts for 2005 amount to US$ 2.3 
billion including resources needed to finance phase II of successful programmes approved in 
the past (US$ 1.3 billion) and the cost of a new round of proposals (US$ 1 billion) to be 
officially launched in March 2005. 
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The actual gap for 2005 is therefore US$ 0.9 billion. This fully justifies an appeal to the 
donor community by the Chair of the GFATM Board and the Fund Executive Director. At the 
Stockholm meeting (14/16 March 2005), GFATM donors will therefore be requested to 
confirm their pledges for 2005. 
Table II 
  
Pledges to date for the years 2005 – 2007 
in US$ 
  GFATM DONORS 
  
2005 2006 2007 
Australia    3,878,976   
Belgium    6,601,307  6,601,307  6,601,307 
Canada    56,451,613   
China    2,000,000  2,000,000  2,000,000 
Denmark    24,604,569    
European Community1    76,049,213  36,057,816  
France    196,078,431  196,078,431  
Germany    107,189,542  94,117,647  96,078,431 
Italy    130,718,954   
Netherlands    60,130,719   
Russia    5,000,000  5,000,000  
Saudi Arabia    2,500,000  2,500,000  
Singapore    200,000  200,000  200,000 
Spain    15,000,000  35,000,000  
Thailand    1,000,000  1,000,000  1,000,000 
Uganda    500,000  500,000  500,000 
United Kingdom    91,194,969  96,855,346  96,855,346 
United States    435,000,000  200,000,000  200,000,000 
Total   1,214,098,293  675,910,547  403,235,084 
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Note to the table: 
1: The EC pledges to the GFATM are in Euros (€58 million in 2005 and €27.5 million in 
2006 ) and have been converted in US dollars applying the US$/€ exchange rate at 1 March 
2005 
5.2. GFATM funding needs in 2006 and 2007 
In the run-up to the first Replenishment Meeting, the GFATM Secretariat has circulated to the 
GFATM donors an estimate of future financial needs based on the Fund’s current business 
model (see Table IV. The annual level of resources needed is calculated by adding the cost of 
the renewal (phase II) of grants approved in previous years to the cost of financing new 
rounds of proposals of US$ 1 billion each (the GFATM plans to launch 1 round in 2005, 1 in 
2006 and 2 in 2007). Based on such calculations, the financing needs of the GFATM would 
amount to US$ 2.3 billion in 2005, US$ 3.5 billion in 2006 and approximately US$ 3.6 
billion in 2007. 
 
Table III 
 
Based on the resource needs estimated by the GFATM Secretariat and considering the total 
pledges currently available for 2005, 2006 and 2007, it clearly emerges that the GFATM is 
going to face a serious resource gap in the years to come (see Table III). 
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Table IV 
 
From the above estimates, it is clear that the annual level of donor contributions to the 
GFATM would have to more than double compared to the 2004 level of contributions 
(approximately US$ 1.4 billion out of which more than US$ 0.7 billion was provided by the 
EU alone) to respond to the drastic increase in demand for financial resources (see Table V). 
 
Table V 
  
  EU DONORS 
  
AMOUNT 
CONTRIBUTED 
2001/2002 
In US$ 
AMOUNT 
CONTRIBUTED 2003 
In US$ 
 
AMOUNT 
CONTRIBUTED 2004 
In US$ 
Austria    1,075,900   
Belgium    12,207,409  7,229,938  10,270,518 
Denmark    14,816,511  13,790,866  16,188,433 
European Community    137,064,385  50,360,226  264,413,350 
France    58,981,250  63,679,739  196,078,431 
Germany    11,995,200  37,427,325  45,944,850 
Hungary      10,000 
Ireland    9,835,000  11,161,430  12,299,000 
Italy    108,618,673  106,541,600  
Phase I
Rounds 1 - 4 3,087
Round 5 1
Round 6 1,1
Round 7 2,6
Round 8
Phase II
Rounds 1 - 4 0,12 1,311 2,403 0,438
Round 5 0,574
Total (US$ bio) 3,207 2,311 3,503 3,612
2007(in bio. US$) 2002-2004 2005 2006
Grants Approved Through 2007Grant Round
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Luxembourg    1,037,500  1,094,820  3,410,752 
Netherlands    8,087,400  43,590,360  54,344,679 
Poland     20,000  10,000 
Portugal     400,000  600,000 
Slovenia      5,479 
Spain     35,000,000  15,000,000 
Sweden    22,369,965  11,488,363  47,811,683 
United Kingdom    78,215,278  40,032,750  60,333,210 
Total    464,304,471  421,817,416  726,720,385 
If we look at the distribution of contributions over the years (from 2001/02 to 2004), the EU 
(EC and Member States) has been the largest donor to the GFATM, providing approximately 
between 48% and 55% of the total resources (the difference in the EU share per year is mainly 
due to the recent depreciation of the US dollar). The second-largest donor to the GFATM has 
traditionally been the USA. 
Tables VI and VII show the contributions to the GFATM in the years 2001/02–2004 of, 
respectively, non-EU public donors and private donors including foundations, corporations 
and private individuals. 
Table VI 
  
  Non-EU PUBLIC DONORS 
  
AMOUNT 
CONTRIBUTED 
2001/2002 
In US$ 
AMOUNT 
CONTRIBUTED 
2003 
In US$ 
AMOUNT 
CONTRIBUTED 
2004 
In US$ 
Andorra    100,000   
Australia      13,827,500 
Barbados     100,000  
Brazil     50,000  
Burkina Faso    75,000   
Cameroon      
Canada    25,000,000  25,000,000  50,005,530 
China     2,000,000  2,000,000 
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Iceland      206,299 
Japan    80,400,337  79,993,443  104,726,233 
Kenya    8,273   
Korea (Republic of)      500,000 
Kuwait     1,000,000  
Liechtenstein    100,000   77,190 
Mexico      
Monaco    44,000  44,000  44,000 
New Zealand     734,000  625,200 
Nigeria    9,080,914   
Norway    17,962,003  17,709,581  17,864,799 
Russia    1,000,000  4,000,000  5,000,000 
Saudi Arabia     2,500,000  2,500,000 
Singapore      200,000 
South Africa     2,000,000  
Switzerland    5,594,133  4,405,973  2,343,384 
Thailand     1,000,000  1,000,000 
Uganda      500,000 
United States    300,000,000  322,725,000  458,881,279 
Zambia    25,000   
Zimbabwe     158,462  
Total    439,389,660  463,420,459  660,301,414 
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Table VII 
  
  PRIVATE DONORS 
  
AMOUNT 
CONTRIBUTED 
2001/2002 
In US$ 
AMOUNT 
CONTRIBUTED 
2003 
In US$ 
AMOUNT 
CONTRIBUTED 
2004 
In US$ 
Foundations and Not-for-profit Organizations  
Gates Foundation    50,000,000  50,000,000  50,000,000 
Int'l Olympic Committee    100,000   
Other    20,124  31,838  71,505 
Total    50,120,124  50,031,838   50,071,505 
Corporations     
Eni S.p.A.    500,000   
Winterthur    1,044,225   
Other    17,755  2,033  296,498 
Total    1,561,980  2,033  296,498 
Individuals, Groups & Events   
Mr Kofi Annan    100,000   
Amb. D. Fernandez    100,000   
Health Authorities of Taiwan    1,000,000   
Real Madrid Soccer Match    112,487   
Treatment Action Campaign     10,899  
Other    242,213  120,343   499,356 
Total    1,554,700  131,242  499,356 
     
Grand Total    53,236,804  50,165,113  50,867,359 
6. THE EC CONTRIBUTION TO THE GFATM BETWEEN 2001 AND 2006 
The EC made pledges to the GFATM covering the period 2001-2006 for a total amount of 
€460 million (see Table VIII). 
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The first pledge amounting to € 120 million (€ 60 million from the 6th and 7th EDF and € 60 
million from the budget) covered the period 2001–2002 (it should be noted however that the 
biennium 2001/2002 is considered by the GFATM as one budget year). This amount was fully 
disbursed by the EC in 2002. 
At the June 2003 G8 Summit in Evian (France), the EC announced further contributions to the 
GFATM totalling € 340 million (€ 170 million from the budget and € 170 million from the 
9th EDF) covering the four-year period 2003–2006. 
When approving the 2005 budget, the European Parliament agreed to increase the 2005 EC 
contribution to the GFATM by €15 million. However, from a budgetary point of view this 
additional contribution in 2005 is being considered as a frontloading of the 2006 contribution 
to the GFATM. 
Taking into account the fact that 2001/2002 constitutes only one budgetary year for the 
GFATM, the average annual EC pledge between 2001 and 2006 is approximately €92 million 
(Over the 6 EU budget years the average is €76.5 million). 
Table VIII 
EC pledges and contributions to the GFATM 
(in EURO) 
      
Source 2001/2002 2003 2004 2005 2006 
6th and 7th EDF 60     
9th EDF   170   
Budget 60 42 42.5 58 27.5 
Total 120 42 212.5 58 27.5 
Up to the end of December 2004 the EC disbursed a total of € 374.5 million, which represents 
approximately 80% of the total pledge (€ 460 million) for the entire period 2001–2006. In 
particular, in 2003 and 2004 the EC disbursed respectively € 42 million and € 212.5 million. 
The EC agreed in 2004 to frontload the entire EDF portion (€ 170 million) of its contribution 
for 2003-2006. 
7. FUTURE ROLE OF THE EU IN THE GFATM 
The EU’s role in the efforts to fight the three diseases has substantially increased including in 
research.  
With a view to the Replenishment Conference to be held in September 2005, the EU must 
engage in a thorough debate on how to divide up its annual contribution to the GFATM 
among its Member States and the EC. The replenishment process ahead of us constitutes a 
great opportunity for the EU to confirm its political commitment to the fight against 
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HIV/AIDS, malaria and tuberculosis. While the Commission is aware of the fact that the 
financial framework made available by the major organizations dealing with the three 
diseases is quite tentative and likely to evolve in the coming months, it fully acknowledges 
the call for additional financial resources to be provided to meet partner countries’ need to 
confront the diseases. The GFATM is clearly a privileged channel to meet those needs, 
although not the only one. 
Over the last 18 months all GFATM stakeholders (EU and non-EU donors alike) have often 
discussed the implications of an increased level of resources, including different models and 
approaches for the distribution among donors of the financial burden of fighting the three 
diseases. In this paper, the Commission presents some of the options: 
• The EU (EC and Member States) could provide 50% or more of the global external 
resources to be channelled to the GFATM on an annual basis, following the pattern of the 
last 3 years. Such an option would ensure EU leadership in the fight against the three 
diseases through a substantive role in the GFATM. Nevertheless, considering that the 
resource needs of the GFATM will progressively increase, it might be quite difficult for 
the EU to attain such a high share of the global contributions. 
• The EU (EC and Member States) could provide at least 33% of the global external 
resources to be channelled annually to the GFATM. This option emerged at the June 2003 
G8 Summit in Evian (France), where several world leaders strongly reiterated the need for 
the donor community to provide financial support to the fight against the three diseases, 
particularly though the GFATM. Under this proposal, resources would be equally shared 
between the EU (EC and Member States), the US and other non EU-donors (Japan, 
Canada, private sector, etc). The principle was strongly reiterated at the Donors’ Meeting 
of the GFATM held in Paris on 16 July the same year. In connection with this position, the 
US Congress approved a bill in 2003, according to which the US annual contribution to the 
GFATM could not exceed 33% of the overall contributions provided in a given year. 
Should this option be adopted, the EU would certainly lose some credibility for reducing 
its financial involvement in the GFATM quite drastically (from approximately 50% to 33% 
of the total contributions). 
With a view to the Replenishment Conference, the EU should discuss how the future 
European contribution to the GFATM could be shared among its partners. The Commission 
acknowledges that EU partners’ contributions have been decided so far on a voluntary basis. 
However, it believes that the introduction of a replenishment mechanism calls for a more 
structured contribution scheme and therefore presents the following options for discussions 
among the partners: 
• Current EU donors (including the EC) proportionally increase their annual contribution to 
the GFATM based on the level of resources provided in the last two years (2003 and 
2004). 
• New EU donors join the GFATM (at present only 17 EU Member States have provided a 
financial contribution to the GFATM), which would enable the key for each EU donor’s 
contribution to be reviewed, since the financial burden would be shared among a larger 
number of European partners. 
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• All EU Member States agree to contribute to the GFATM and to apply the GNI key to 
calculate the contribution of each individual donor. Should this option be applied, the EC 
annual contribution would be calculated according to a different key. 
